In this issue of the JCI, Maillard et al. identified an additional molecule that influences cellular TP pharmacology and pharmacogenomics in ALL — NUDIX hydrolase 5 (NUDT5) (18). Here, NUDT5 is linked to acute lymphoblastic leukemia.